H. Kirchner
About
In The Last Decade
H. Kirchner
29 papers receiving 657 citations
Peers
Comparison fields: 5 of 76
- Oncology 393
- Immunology 274
- Pathology and Forensic Medicine 157
- Pulmonary and Respiratory Medicine 148
- Molecular Biology 134
Countries citing papers authored by H. Kirchner
This map shows the geographic impact of H. Kirchner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Kirchner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Kirchner more than expected).
Fields of papers citing papers by H. Kirchner
This network shows the impact of papers produced by H. Kirchner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Kirchner. The network helps show where H. Kirchner may publish in the future.
Co-authorship network of co-authors of H. Kirchner
This figure shows the co-authorship network connecting the top 25 collaborators of H. Kirchner. A scholar is included among the top collaborators of H. Kirchner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Kirchner. H. Kirchner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 112 | |
| 3 | 13 | |
| 4 | 125 | |
| 5 | 99 | |
| 6 | 13 | |
| 7 | In vivo tumor necrosis factor-alpha as indicator of biologic and clinical response to low-dose SC recombinant interleukin 2. | 3 |
| 8 | European studies of interleukin-2 in metastatic renal cell carcinoma. | 23 |
| 9 | In vivo and ex vivo antitumor activity in patients receiving low-dose subcutaneous recombinant interleukin-2. | 7 |
| 10 | Diminished expression of interleukin-2 receptors in vivo after prior chemotherapy in advanced cancer patients receiving recombinant interleukin-2. | 2 |
| 11 | alpha-Interferon and interleukin-2 in renal cell carcinoma: studies in nonhospitalized patients. | 29 |
| 12 | 70 | |
| 13 | Subcutaneous interleukin-2 and interferon-alpha 2b in patients with metastatic renal cell cancer: the German outpatient experience. | 23 |
| 14 | 1 | |
| 15 | 9 | |
| 16 | 7 | |
| 17 | [Interferon production and lymphoproliferation in whole blood of schizophrenia patients]. | 1 |
| 18 | 48 | |
| 19 | 14 | |
| 20 | Kinetics of the Zn 2+ - stimulation of human peripheral lmphocytes in vitro. | 13 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.